Nanomedicine is the medical application of nanotechnology achieved by combining nano- and biomaterials with the future perspective to address pathologies in a complex and heterogeneous scenario. The challenge of nanomedicine depends on the use of nano- and biomaterials at the nanometer scale to manufacture scalable drug delivery systems and medical devices that are safe, biocompatible, and non-toxic. The goal is to selectively target microenvironments and tissues through physiological and pathological mechanisms that modulate the micro- and macro environments of patients affected by rare and clinically relevant pathologies.

The combination of nano- and biomaterials, the modification of interface properties, as well as the functionalization of the resulting drug delivery systems with macromolecules and active biomolecules, provides specific properties for tailoring precision medicine. This boosts the application for many diseases with suitable therapeutic options and benefits for the patients.T

This symposium will address the latest advances of nanomedicine for precise targeting therapies and unlock their potential for drug and gene delivery applications. The selected talks will provide insights on the latest developments of translational research on nanomedicine for a personalized therapy and towards a reliable pre-clinical and clinical assessment.

 

Scientific Committee

• Hélder Santos / University of Groningen, The Netherlands
• Neus Feliu Torres / Fraunhofer IAP, Potsdam, Germany
• Wolfgang Parak / University of Hamburg, Germany

Topics Include

• Bionanomaterials synthesis and characterization
• Nanomaterials for medicine
• Nanotechnology in therapy
• Nanotechnology in medical diagnostics
• Pharmaceutical nanotechnology

 

Speakers Include

• Matthias Barz / Leiden University, Netherlands
• Chunying Chen / National Center for Nanoscience and Technology, China
• Wenguo Cui / Shanghai Jiao Tong University of Medicine, China
• Kenneth Dawson / University College Dublin, Ireland
• Helena Florindo / University of Lisbon, Portugal
• Ana Beloqui Garcia / Louvain Drug Research Institute, Belgium
• Twan Lammers / RWTH Aachen, Germany
• João Mano / University of Aveiro, Portugal
• Michael Mitchell / University of Pennsylvania, USA
• Wolfgang Parak / University of Hamburg, Germany
• Dan Peer / Tel-Aviv University, Israel
• Beatriz Pelaz / University of Santiago de Compostela, Spain
• Pablo del Pino / University of Santiago de Compostela, Spain
• Jai Prakash / University of Twente, Netherlands
• Avi Schroeder / Technion, Israel
• Stefaan de Smedt / Ghent University, Belgium
• Hélder Santos / University of Groningen, Netherlands
• Tambet Teesalu / University of Tartu, Estonia
• Neus Feliu Torres / Fraunhofer IAP, Germany
• Maria Vincent / CIPF, Spain
• Yan Yan / University College Dublin, Ireland

 

Follow on X (formerly Twitter): #BeilsteinNanomedicine2024

 

Event Details